dehydroretronecine has been researched along with Experimental Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jago, MV; Jarrett, RG; Peterson, JE; Reddy, JK | 1 |
| Allen, JR; Hsu, IC; Robertson, KA; Shumaker, RC | 1 |
| Allen, JR; Johnson, WD; Pounds, JG; Robertson, KA | 1 |
3 other study(ies) available for dehydroretronecine and Experimental Neoplasms
| Article | Year |
|---|---|
Neoplasia and chronic disease associated with the prolonged administration of dehydroheliotridine to rats.
Topics: Age Factors; Animals; Body Weight; Injections, Intraperitoneal; Liver; Lung; Monocrotaline; Neoplasms, Experimental; Pyrrolizidine Alkaloids; Rats; Thioacetamide | 1983 |
Neoplastic transformation in tissues of rats exposed to monocrotaline or dehydroretronecine.
Topics: Animals; Carcinogens; Carcinoma, Hepatocellular; Injections, Subcutaneous; Liver Neoplasms; Male; Monocrotaline; Neoplasm Metastasis; Neoplasms, Experimental; Pyrrolidines; Pyrrolizidine Alkaloids; Rats; Rhabdomyosarcoma | 1976 |
Dehydroretronecine-induced skin tumors in mice.
Topics: Administration, Topical; Animals; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Injections, Subcutaneous; Mice; Monocrotaline; Neoplasms, Experimental; Pyrrolizidine Alkaloids; Skin Neoplasms | 1978 |